HALIX facility approved for AstraZeneca’s COVID-19 vaccine active substance manufacturing On Friday, March 26th 2021, HALIX’s facility has been approved…
NovalGen enters strategic partnership with HALIX B.V. to manufacture clinical trial materials London, United Kingdom and Leiden, The Netherlands, February…
New cGMP facility starting operational production in Q4-2019 HALIX meets aggressive timelines for new manufacturing facility Leiden, the Netherlands, August…